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Abstract
Due to their well-characterized neural development and high genetic homology to mammals, 
zebrafish (Danio rerio) have emerged as a powerful model organism in the field of biological 
psychiatry. Here, we discuss the molecular psychiatry of zebrafish, and its implications for 
translational neuroscience research and modeling CNS disorders. In particular, we outline recent 
genetic and technological developments allowing for in-vivo examinations, high-throughput 
screening and whole-brain analyses in larval and adult zebrafish. We also summarize the 
application of these molecular techniques to the understanding of neuropsychiatric disease, 
outlining the potential of zebrafish for modeling complex brain disorders, including attention-
deficit/hyperactivity disorder (ADHD), aggression, post-traumatic stress and substance abuse. 
Critically evaluating the advantages and limitations of larval and adult fish tests, we suggest that 
zebrafish models become a rapidly emerging new field in modern biological psychiatry research.
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1. Introduction
Psychiatric disorders affect many brain and behavioral processes, including thoughts, 
feeling, sociability and mood. These complex human diseases also cause a significant 
burden to society, especially as the available drug therapies have not sufficiently 
progressed1, 2. The etiology of psychiatric disorders is multifaceted, and involves the 
interaction of multiple genetic and environmental factors.
Genetic mutations trigger psychiatric disorders by altering gene expression and disrupting 
normal physiological functions of the brain. Mutations linked to psychiatric disorders are 
often found in genes expressed during embryogenesis, and affect early brain development, 
cell division, migration, differentiation or survival, as well as axon path finding, dendritic 
architecture and wiring of neural circuits. For example, Rett syndrome is caused by 
mutations in the X-linked MECP2 gene, encoding methyl CpG binding protein-2 that binds 
to methylated DNA and controls gene expression3. While MECP2 is particularly critical 
during brain development, its mutations are also associated with other ‘early-onset’ 
developmental brain disorders, such as X-linked mental retardation and autism3 (also see the 
substantial contribution of mutations in genes with higher expression in early fetal life to 
schizophrenia4). Environmental factors also play an important role in psychiatric disorders, 
leading to well-established gene × environment (G × E) interactions5.
The notion that psychiatric disorders have fundamental underlying molecular mechanisms is 
critical for understanding complex brain illnesses, such as anxiety, depression, schizophrenia 
or addiction. The promise of such an approach is that once these mechanisms are identified 
and understood, the brain disorder can be treated, reversed or prevented6, 7.
Clearly ‘mainstream’ today, molecular psychiatry had a long journey before being accepted 
as a new, dynamic field of translational neuroscience7. Utilizing various in-vivo tests and 
applying a wide range of model organisms (Fig. 1) is critical for uncovering novel 
mechanisms of brain disorders8. Zebrafish (Danio rerio) have long been underrepresented in 
experimental biological psychiatry, and only recently emerged as a model organism in this 
field9–11. It is therefore timely to discuss the molecular psychiatry of zebrafish and its 
implications for clinical as well as translational neuroscience research.
2. The utility of zebrafish for translational neuroscience
2.1. Understanding ‘zebrafish psychiatry’
While zebrafish represent a powerful model for developmental neuroscience (Fig. 1), a 
combination of well-characterized neural development and several cutting-edge genetic 
tools also makes them an ideal species to study complex psychiatric disorders. Although 
similar manipulations are often available in other vertebrates (e.g., mice), the ease of 
generating large numbers of fish, their external fertilization and transparent embryonic/larval 
stages are particularly useful, also facilitating high-throughput screening and CNS 
imaging10, 11. Zebrafish also have an excellent potential to link genes to CNS disorders, 
because the nucleotide sequence of zebrafish genes is homologous (usually exceeding 70%) 
to corresponding human genes, and their function in these distantly related species is often 
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similar12. As zebrafish genes can be mutated with high efficiency, the strains (lines) 
carrying interesting mutations may be detected using phenotype screens, and the mutated 
genes can be efficiently identified genetically (see further). Once genes involved in 
particular functions are identified using such ‘forward genetic’ strategy, their biological 
role(s) may be thoroughly investigated using ‘reverse genetic’ methods, specifically 
developed for zebrafish (e.g., the ‘transcription activator-like effector nuclease’ TALEN 
system13, allowing targeted mutation of pre-selected sequences). Thus, to the extent that a 
psychiatric disease can be modeled in any animal by the generation of a genetic mutant or 
by pharmacological manipulation, zebrafish present a useful, cost-effective and uniquely 
tractable system.
While aberrant neurotransmission is one of the main causes of psychiatric disorders6, 7, 
vertebrate neurochemistry is generally highly conserved14–17. Zebrafish possess all primary 
neuromediator systems, including transmitters, receptors, transporters and the enzymes 
required for synthesis and metabolism of these mediators10, 11. The spatial and temporal 
distribution of these systems has been well characterized in both larval and adult zebrafish 
for glutamate, γ-aminobutyric acid (GABA), acetylcholine and the aminergic 
neurotransmitters dopamine (DA), noradrenaline (NA), serotonin (5-HT) and histamine 
(HA, Fig. 2B) – key mediators implicated in multiple psychiatric diseases.
2.2. Major neurotransmitter systems in zebrafish
Glutamate is the primary excitatory CNS neurotransmitter involved in schizophrenia, post-
traumatic stress disorder (PTSD) and epilepsy. Glutamate signaling is visualized using in 
situ hybridization for vesicular glutamate transporters (VGLUT1 and VGLUT2)18, and 
glutamate metabotropic (mGluRs) and ionotropic (iGluRs) receptors, including three 
subtypes N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPA) and kainate. VGLUT2 is found in zebrafish 
embryos beginning at 20–24 h post fertilization (hpf) in Rohon Beard neurons and in the 
mediodorsal domain of the zebrafish spinal cord19. As the fish develops, there is an increase 
in existing areas of expression, as well as the formation of new domains throughout the 
spinal cord. By 4–5 days post fertilization (dpf), VGLUT1 and VGLUT2 are distributed 
throughout the majority of the midbrain, hindbrain and spinal cord19. Examination of the 
expression patterns of mGluRs in zebrafish reveals a similar pattern to that seen in rodents, 
with mGluR expression in larval and adult zebrafish found in the olfactory bulb, optic 
tectum, hypothalamus, cerebellum and retina20. Zebrafish also possess high-affinity 
excitatory amino acid transporters (EAATs), which regulate glutamate levels and prevent 
excitotoxicity. Four of the five EAAT-related genes are found in the zebrafish genome, 
including three EAAT1 paralogs, EAAT2, EAAT3, and two EAAT5 sequences21.
GABA is the primary inhibitory neurotransmitter in the adult CNS, modulating neuronal 
excitability and also exerting its action during development. Altered GABA and glutamic 
acid decarboxylase (GAD, the enzyme producing GABA from glutamate) are seen in many 
CNS disorders, including ADHD, bipolar disorder and major depression22–24. Expression 
patterns of GABA are usually investigated by direct immunostaining for GABA or the two 
GAD isoforms (GAD65 and GAD6725), as well as by visualizing the ionotropic and 
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metabotropic GABAA/C and GABAB receptors26. In the embryonic zebrafish, GABA-
immunoreactive (ir) cells can be detected very early during development. By 16 hfp, 
GABA-ir cells are found in the telencephalic nucleus, the nucleus of the tract of the 
postoptic commissure, the nucleus of the medial longitudinal fascicle, and throughout the 
hindbrain and spinal cord27. At 24 hpf, existing ir-cell clusters increase in cell numbers, and 
new clusters are located in the dorsomedial nucleus of the posterior commissure and the 
primordium of the hypothalamus. As the zebrafish develops, three identifiable GABAergic 
axonal projections include the supraoptic tract, the tract of the postoptic commissure and the 
medial longitudinal fascicle. By 3 dpf, the distribution of GABA-ergic neurons in the 
zebrafish brain is very similar to its mammalian counterparts at a corresponding 
developmental stage28. GABA-ir cells are widely distributed, locating in the olfactory bulb, 
subpallium, posterior preoptic area, the diencephalic basal plate, the central optic tectum, 
torus semicircularis, ventral mesencephalic tegmentum, valvula of the cerebellum and 
medulla oblongata19, 28. In adult zebrafish, GABA is broadly distributed. GABA-ergic 
expression in the telencephalon is very similar to embryonic zebrafish, with GABA-ir cells 
in the internal cellular layer of the olfactory bulb29 and all regions of the subpallium, as well 
as the preoptic, pretectal, ventral, thalamic, hypothalamic, preglomerular and posterior 
tubercular nuclei, cerebellar corpus, valvus and vestibulolateral lobe25, 26.
DA and NA are the primary catecholamine neurotransmitters in zebrafish. DA plays a key 
role in modulating learning, memory, motor control, food intake, and motivation. Deficits of 
DA neurotransmission have been implicated in bipolar disorder, schizophrenia, ADHD and 
drug addiction. NA-ergic neurons serve an important function in the autonomic nervous 
system, but also modulate attention, arousal, reward, depression and schizophrenia. In 
zebrafish, the catecholaminergic signaling pathways have been characterized by visualizing 
the temporal and spatial expression of tyrosine hydroxylase (TH)30, 31 or the th transcript32 
in all catecholaminergic neurons, the dopamine transporter (dat) for DA neurons and 
dopamine beta hydroxylase (dbh) for NA neurons33, 34, and the three zebrafish DA receptors 
D1, D2 and D3 35, 36. Zebrafish DA-ergic neurons are first formed in the telencephalon 
(olfactory bulb and subpallium) and diencephalon (preoptic area, pretectum, ventral 
thalamus, posterior tuberculum, and hypothalamus) with projections that terminate 
locally30, 33. In adult zebrafish, th1 and th2 are differentially expressed, with th1 expressed 
in the telencephalon, ventral thalamus and pretectum, th2 more broadly distributed in the 
hypothalamus, and both genes strongly expressed in the posterior tuberculum and preoptic 
region32. There are some notable differences between zebrafish and mammals: for example, 
zebrafish lack DA-ergic cell groups in the mesencephalon14, 33 and ventral midbrain37, but 
possess an additional pretectal group18. The zebrafish NA system is very similar to 
mammals, with NA cell groups located in the locus coeruleus, medulla oblongata and area 
postrema38, 39. Zebrafish NA neurons can already be identified by 16 hpf, with few changes 
between larval and adult fish40. Projections from NA neurons are also conserved between 
zebrafish and mammals37, with neurons in the locus coeruleus projecting to the 
telencephalon, diencephalon and mesencephalon, in the medulla projecting to the hindbrain 
and spinal cord, and the in the area postrema projecting to the same areas as the locus 
coeruleus40.
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HA also plays a key role in regulating diverse brain functions (e.g., higher cognitive 
functions, circadian rhythms, locomotor activity) and modulating other aminergic systems. 
The zebrafish HA-ergic system is very similar to other vertebrates, with L-histidine 
decarboxylase and three of the four HA receptors (H1, H2, and H3) found in the brain41. 
The first HA-ir neurons detected in zebrafish embryos are located in the ventral 
hypothalamus at ~85 hpf, and by 90 hpf the first ir-fibers can be detected in the dorsal 
telencephalon42. In adult zebrafish, HA-ir neurons are found in the ventrocaudal region of 
the hypothalamus surrounding the posterior recess16 and innervate every major region in the 
brain (except the cerebellum)14.
5-HT mediates excitatory and inhibitory neurotransmission, serving a critical role in 
aggression, anxiety, cognition, learning, memory, mood and sleep. Perturbation of 5-HT 
levels during development have been implicated in abnormal psychiatric behaviors, such as 
anxiety spectrum disorders, schizophrenia and depression43. Zebrafish express four 5-HT 
receptors (htr1aa, htr1ab, htr1bd, and htr2c)44, 45, the spatial expression of which in the 
brain is primarily visualized by immuno-histochemistry and in situ hybridization46. More 
recently, transgenic strains expressing enhanced green fluorescent protein (eGFP) under 
control of the zebrafish raphe-specific gene pet1 have also been developed47. 5-HT neurons 
are expressed in the spinal cord of embryonic zebrafish by 1 dpf, with additional clusters 
distributed throughout the brain (including the telencephalon and hindbrain) by 5 dpf 30, 48. 
In adult zebrafish, 5-HT neurons are primarily located in the raphe nucleus with ascending 
projections terminating in the telencephalon, diencephalon, tegmentum, hindbrain and spinal 
cord47. Additional groups of anatomically distinct clusters of 5-HT-ir cells are also found in 
the pineal, pretectal area, posterior tuberculum and hypothalamus, reticular formation, area 
postrema and spinal cord14, 47, 49. 5-HT neurons have also been identified by the expression 
of other markers, such as three tryptophan hydroxylase genes (tph1a, tph1b and tph2)50, 51, 
two 5-HT transporters genes (serta and sertb)44, 52, and two vesicular monoamine 
transporter genes (vmat1 and vmat2)53. Examination of the transporter genes permits more 
specific analysis of temporal and spatial expression pattern of 5-HT, since it can be unique, 
with serta expressed in the pineal, pretectal area, and raphe, and sertb in the retina, posterior 
tuberculum/hypothalamus and area postrema54.
Acetylcholine plays a fundamental role in CNS functions (e.g., sleep, learning/memory and 
attention) and dysfunctions (e.g., schizophrenia, ADHD and depression). The zebrafish 
cholinergic system is generally similar to other vertebrates, with both muscarinic55 and the 
full set of nicotinic receptors56, 57. The distribution of cholinergic neurons in the zebrafish 
brain has been primarily described by mapping the enzymes choline acetyltransferase 
(ChAT) and acetylcholinesterase (AChE). Cholinergic-ir neurons first appear immediately 
after hatching in the zebrafish embryo optic tectum. By 60 hpf, additional cells are seen in 
the preoptic area and tegmentum, and by the completion of the embryonic stage, additional 
reactivity is seen in the isthmic region and medulla oblongata58. Adult zebrafish display 
widespread distribution of both ChAT and AChE. AChE-ir neurons are found in the preoptic 
region, periventricular layer of the optic tectum, rostral tegmental, oculomotor, trochlear 
nuclei of the mesencephalic tegmentum, isthmic region, octaval nuclei and motor nuclei of 
the cranial nerves59. In contrast, ChAT-ir neurons are located in the pretectum and the 
Stewart et al. Page 5
Mol Psychiatry. Author manuscript; available in PMC 2015 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
tectum, except the marginal layer, the mesencephalic tegmentum, isthmic region, in Purkinje 
and granule cells in the cerebellum, and throughout the medulla.
Finally, it is important to consider the fish-specific genome duplication that occurred around 
450 million years ago60. In zebrafish, this duplication resulted in expressing more 
neurotransmitter receptors than other species. For example, zebrafish have an estimated 122 
G-protein coupled receptors for biogenic amines (such as 5-HT, noradrenaline, dopamine, 
histamine, adrenaline and trace amines), compared to 57 in mouse and 44 in humans61. 
Importantly, not all zebrafish receptor paralogs have been identified and characterized. For 
example, to date only three 5-HT receptors have been cloned, despite the existence of seven 
distinct 5-HT receptor families in other animals44. Furthermore, the functional and 
pharmacological properties of zebrafish receptors have not been well studied62, making it 
more difficult to translate information across species. One reasonably well characterized 
group is the alpha-2 adrenoceptors (adra2). The zebrafish genome contains five adra2 
receptors, three of which (adra2a, adra2b and adra2c) are conserved with mammals63. 
However, the other two subtypes, adra2da and adra2d, are zebrafish-specific, whereas 
mammalian adra2a-c paralogs are not found in fish. Strikingly, despite fairly low sequence 
homology (~55% overall, rising to ~75% in the trans-membrane domains), human and 
zebrafish receptors show similar ligand-binding profiles64. For example, the adra2 agonist 
dexmedetomidine acts as a sedative in zebrafish and other species, an effect that can be 
inhibited by the adra2-specific antagonist atipamezole65. Thus, while the function of these 
receptors appears to be conserved across species65, the increased number of neurotransmitter 
receptors in zebrafish (vs. mammals) means that their pharmacological and functional 
properties must be carefully examined before translating them to other species. In particular, 
the above-mentioned sub-functionalization of receptor subtypes implies that manipulating 
genes linked to psychiatric disorders may not recapitulate all symptoms of a disease, and 
that some novel drugs characterized in fish may have different pharmacological properties in 
humans (see further).
2.3. Visualizing zebrafish CNS signaling pathways
Imaging neural patterns and circuits is a key strategy in biopsychiatry research, and 
zebrafish offer a highly amenable experimental model for investigating the spatiotemporal 
distribution of neurotransmitter systems. In addition to conventional immunohistochemistry 
for neurotransmitter proteins or in situ hybridizations for the transcripts, recent genetic and 
technological developments permit in-vivo screening, high-throughput analyses and whole-
brain assays in this model organism.
Larval zebrafish are particularly suited for translational models of psychiatric disease 
because they are small, undergo external development, and are transparent (until all major 
organs, including the brain, have fully developed)10, 11. This permits neurons in larval fish 
to be easily observed in-vivo and then ablated or manipulated. A wide range of genetic tools, 
developed or adapted to zebrafish to transiently alter gene expression and generate knockout 
disease models, includes antisense oligonucleotides (the morpholinos), zinc finger 
nucleases66, TALEN13 and ‘targeting induced local lesions in genomes’ (TILLING)67. 
Similar to invertebrate models, novel mutants or small molecules can then be rapidly 
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screened (in the thousands) using a combination of conventional fluorescent or confocal 
microscopy with automated fluidic screening platforms68, 69.
Complementing multiple genetic methods, a suite of sophisticated tools also help elucidate 
the anatomical alterations associated with novel phenotypic alterations. These techniques 
include in-vivo monitoring of neural activity, functional analyses of specific neurons, and 
tracing of neural circuits. Genetically encoded calcium indicators (GECIs, such as the 
GCaMP reporter constructs) fluoresce when calcium is present, thereby serving as an 
indicator for action potential firing70. By driving expression with the Gal4/UAS71 or 
transposon-based Tol2 systems72 GECIs and optogenetic constructs, such as 
channelrhodopsin and halorhodopsin, can easily be inserted into the zebrafish genome to 
target specific cellular populations and perform functional analyses. With advanced 
microscope techniques (e.g., light-sheet microscopy), functional imaging of the entire brain 
of a larval zebrafish can be performed in less than 1.5 s73, a task unattainable in other 
vertebrate models. In contrast to rodents, this procedure is also almost entirely non-invasive, 
and does not require attaching fiber optic cables. Albeit currently used in zebrafish to 
address fundamental questions (e.g., sensory processing74 or motor control75), this 
optogenetic toolbox can be similarly employed in this organism to model altered neural 
activity associated with psychiatric disease in humans76.
Fluorescent markers (e.g., GFP) can also be utilized to resolve the neuronal projections and 
formation of neural circuits in larval zebrafish. Using combinatorial expression of several 
fluorescent proteins to individually label neurons and their projections77, Brainbow 
technology can be particularly useful for examining disease phenotypes related to miswired 
neural circuits (e.g., autism78). Briefly, Brainbow visualizes synaptic circuits by labeling 
neurons genetically, using Cre/lox recombination to create a stochastic choice of expression 
between several fluorescent proteins79–81. Originally developed in mice, this transgenic 
technology has been successfully applied to other model organisms, including zebrafish77, 
to map multiple individual cells within a population and provide a large-scale dissection of 
CNS circuitry80, 81. A recent modification of Brainbow, the Zebrabow, has been introduced 
for in-vivo multicolor imaging in zebrafish82. Applying several new transgenic strains for 
ubiquitous or tissue-specific multicolor labeling, this approach maximizes color diversity by 
optimizing Cre activity, and can be particularly useful for long-term color-based anatomical 
and lineage analyses in a wide variety of zebrafish tissues, including neurons and glia82.
Furthermore, while calcium and voltage sensors are fundamental to functional analyses in 
the larval zebrafish brain, they do not specifically measure neurotransmitter release or 
concentration (typically measured by cyclic voltammetry, HPLC or ELISA). However, more 
recent specific markers enable in-vivo measuring of neurotransmitters, based on placing a 
fluorescent label very close to the synapse, labeling the synaptic vesicle content or directly 
measuring extracellular neurotransmitters. Fluorescent false neurotransmitters (FFNs) are 
optical tracers that permit visualization of neurotransmitter release and uptake at presynaptic 
terminals83. Initially developed for the DA-ergic system, FFNs are fluorescent substrates for 
targeting vesicular monoamine transporter 2, carrying monoamine neurotransmitters to 
synaptic vesicles. FFN has also recently been extended to be a pH-responsive DAT 
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substrate, which is able to identify DA cell bodies and dendrites and measures DAT activity 
and DA release at individual synapses84.
Several optical sensors have also been developed to measure excitatory synaptic activity in 
the brain. The glutamate optical sensor (EOS) is a fluorescent indicator made up of the 
glutamate-binding domain of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor and a small fluorescent molecule bound near the glutamate-binding pocket85. When 
bound to glutamate the EOS changes its fluorescence intensity. Intensity-based glutamate-
sensing fluorescent reports (iGluSnFR) are a single-wavelength glutamate sensor that 
responds to glutamate in situ and therefore directly reports excitatory synaptic release86. 
This sensor can be genetically encoded and used in zebrafish to demonstrate the spatial 
organization of direction-sensitive synaptic activity in the optic tectum86. Finally, 
fluorescent indicators for acetylcholine volume transmission have also been created. Cell-
based sensors of neurotransmitters (CNiFERs) are cultured cells that co-express M1 
muscarinic receptors and the genetically encoded calcium indicator TN-XXL, and (when 
implanted into the brain) provide a fluorescent readout of acetylcholine levels87.
Imaging neurotransmitter systems in the adult zebrafish brain is significantly more difficult 
due to its increased size and lack of transparency. While transparent zebrafish strains (e.g., 
absolute, nacre, and casper, Fig. 1A) exist88, the brains are still relatively opaque making it 
difficult to image the various photo-proteins described above. As a result, studies have 
typically been limited to sectioning the brain. However, numerous methods may render a 
fixed brain transparent and, when imaged with long working distance objectives, permit the 
examination of neurotransmitters in situ89–96. These techniques use hydrophobic or 
hydrophilic chemical mixtures to remove lipids and reduce light scattering to visualize 
endogenous fluorescent markers in the brain.
2.4. Additional zebrafish neuroimaging tools
Several gene transcription factors, such as pair box 3 (Pax3), Fos and Orthopedia (Otp), 
represent a useful tool for visualizing CNS development and function in zebrafish. For 
example, Pax3 is a transcription factor that regulates cell proliferation, migration and neural 
development. Its gene is not only highly conserved (at the sequence level) between zebrafish 
and mammals, but also shows similar pattern of neural expression during 
embryogenesis97–99. Thus, analyses of Pax3 expression in zebrafish can be particularly 
useful for imaging early CNS development97, 98, which is relevant to modeling many 
neurodevelopmental disorders.
The homeodomain transcription factor Otp is an important regulator of neuroendocrine and 
dopaminergic cells in vertebrate species100, 101. Otp has two paralogs in zebrafish (otpa and 
otpb)101, and genetic manipulations suppressing Otp deplete certain dopaminergic neurons, 
enabling a functional dissection of dopaminergic contribution to CNS circuitry in early 
larval zebrafish102.
Likewise, an early proto-oncogene c-fos serves as a well-established marker of neuronal 
activation in various species, including humans103, rodents104, 105 and zebrafish106. For 
example, c-fos expression analyses of whole-brain zebrafish samples can be used to assess 
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neuronal activation globally (e.g., reflecting CNS excitation during epilepsy106, 107 or 
following anxiogenic/anxiolytic or hallucinogenic treatments108, 109). Region-specific 
analyses of c-fos expression in zebrafish brain offer a more detailed functional mapping of 
neural circuits during various behavioral tests110. For instance, in the light-dark test, c-fos 
neuronal activity mapping implicated several brain regions, including several telencephalic 
areas (the teleost homologs of the mammalian amygdala and striatum), during zebrafish 
‘anxiogenic’ light avoidance behavior110. Characterizing neuronal activity induced in 
zebrafish by acute amphetamine, drug-seeking or the light avoidance behavior, quantitative 
analyses of c-fos expression can also be combined with neuronal subtype-specific markers at 
single-cell resolution111. Showing the recruitment of the medial and the lateral pallium 
(structures homologous to the mammalian amygdala and hippocampus), these data suggests 
evolutionarily conserved function of amygdala-like structures in positive emotions and 
motivated behavior in zebrafish and mammals111. Collectively, this evidence strongly 
supports the utility of c-fos and other biomarkers in visualizing normal and aberrant CNS 
development and functioning.
Finally, with the increased use of zebrafish in disease genetics research, a quantitative voxel-
based technique may help compare disease models with wild-type zebrafish. Magnetic 
resonance imaging (MRI) is an inherent 3D tool that facilitates investigations in 
morphology, connectivity and function of the brain. Due to its 3D nature, multiple datasets 
can be mapped to a standard coordinate space and registered to produce a model 
representative of a population (thus, limiting individual morphological variance and instead 
demonstrating the average morphology of the entire population). Data collected from MRI 
can include mean volumes of individual brain regions, the stereotaxic locations of individual 
structures and major fiber bundles, and functional activity. Importantly, MRI models can 
also serve as a canonical space for registration of other imaging datasets. For example, 
recent whole-brain immunostaining and light microscope imaging (e.g. SeeDB or Clarity), 
optical projection tomography and microCT can all be registered to the same stereotaxic 
space, collectively enabling quantitative analysis of a wide range of markers in zebrafish 
brain.
3. Zebrafish models of brain disorders
3.1. Bridging molecular events with behavior
Many psychiatric disorders are moderately or highly heritable, and have developmental 
trajectories112, 113. As behavior is controlled by activity within neural circuits, a major 
challenge is to map the genotype-phenotype relationship in order to understand how genetic 
variations affect neural circuits that control behavior. Various molecular tools have been 
effectively used for uncovering brain mechanisms in zebrafish. For example, in addition to 
traditional N-ethyl-N-nitrosourea (ENU)-induced114 and viral-vector-mediated115 
mutagenesis, new sophisticated ‘gene-breaking transposon’ (GBT)116 screens and ‘clustered 
regularly interspaced short palindromic repeats’ (CRISPR) approaches for generating 
targeted zebrafish mutants have been developed117. Combined with TILLING and TALEN 
tools, this makes the process of exploring genotype-phenotype relationships in zebrafish 
better targeted and less labor-intensive. With the establishment of translationally relevant 
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zebrafish behavioral assays9–11 comes the ability to apply these molecular techniques to 
modeling psychiatric diseases. Here, we discuss how various zebrafish models can be 
utilized to target selected psychiatric disorders and their neurodevelopmental trajectories. 
ADHD, aggression, post-traumatic stress and drug abuse (Fig. 2) were selected as examples, 
reflecting a wide and diverse spectrum of psychiatric disorders that can be modeled using 
the zebrafish.
3.2. Modeling ADHD
Zebrafish have recently been utilized to investigate some aspects of ADHD (Table 1, Fig. 
2A), a common psychiatric disorder affecting ~3–5% of children worldwide. ADHD 
symptoms (inattention, hyperactivity and impulsivity) persist into adulthood in ~50% of 
cases, reducing the patients’ quality of life, academic performance and sociality118, 119. 
Altered DA, NA, 5-HT and glutamate neurotransmission in the prefrontal cortex, striatum, 
parietal cortex, vermis and the inferior lobes of the cerebellum is implicated in 
ADHD120–123.
An interesting example of using larval zebrafish to model this disorder involves a human 
gene LATROPHILIN3 (LPHN3), identified as candidate ADHD gene by linkage analysis124. 
In zebrafish, its homolog latrophilin3.1 (lphn3.1) plays a developmental role, and is 
expressed in differentiated neurons throughout the brain up to 6 dpf. The lphn3.1 morphants 
display increased distance swum at 6 dpf (Fig. 2A)125, 126 - the hyperactivity phenotype also 
maintained during the night, demonstrating a permanent increase in locomotion compared to 
control animals. Morphant larvae also show more bursts of accelerated swimming, 
indicative of motor impulsivity. Both hyperactivity and motor impulsivity can be rescued by 
the prototypical anti-ADHD drugs methylphenidate (MPH) and atomoxetine (Table 1). 
While acute 1-h treatment with either drug had no effect on control-injected larvae at the 
doses used, it rescued morphant behavior bringing locomotion back to control levels. The 
lphn3.1 morphants also display fewer cells in the posterior tuberculum, a prominent group of 
DA-ergic neurons in the ventral diencephalon that control larval locomotion and project 
both anteriorly and posteriorly, but mainly to the spinal cord101, 127. Thus, despite the 
difficulty of fully modeling ADHD in zebrafish, research in these animals show an 
important role for lphn3.1 in DA-ergic neuron development128 (also see similar data in 
mice129, proving the feasibility of translating findings from zebrafish to other species).
Exposure of zebrafish embryos to chemicals during development may also provide insights 
into possible environmental causes of ADHD. For example, prenatal exposure to 
perfluorooctane sulfonate has been linked to clinical adolescent ADHD130, and treating 
zebrafish embryos with this agent during development elicits ADHD-like behaviors in 6-day 
old larvae (i.e., hyperactivity, motor impulsivity and hyper-responsiveness to startle)131. 
This phenotype is reminiscent of the behavior of lphn3.1 larvae and strikingly, these 
behavioral changes can be rescued by dexamfetamine, implicating DA signaling in this 
phenotype. Zebrafish are also used to study the consequences of long-term exposure to 
MPH, displaying elevated DA, NE and 5-HT in the larval brain, and lasting behavioral 
changes (e.g., impaired predatory escape and learning)132. Such ease of conducting 
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embryonic manipulations and behavioral experiments in zebrafish strongly supports their 
potential for studying ADHD and related disorders.
3.3. Zebrafish models of aggression
Aggression, an adaptive animal behavior to monopolize resources, is essential for the 
organism’s fitness and survival. However, pathological aggression is part of various brain 
disorders, and merits further studies in-vivo models. Although aggression has long been 
studied in fishes, the genetic and neurobiological tools available in zebrafish make them an 
ideal species to study aggression. Zebrafish display aggression as a series of stereotypic 
body postures (e.g., undulating body movements, short slaps of the caudal fin and bouts of 
swimming and biting directed against an opponent) which can easily be measured in the 
laboratory133. Aggressive incidents follow a highly structured pattern134, from extending the 
fins to circling, chasing and attempting to bite, further progressing to more frequent chases, 
bites and attempts to strike the opponent. The fish which loses such as encounter becomes 
submissive, exhibiting postures that include fleeing, freezing and retreating134, 135. In 
laboratory zebrafish, aggression can be measured by recording the interaction of two fish in 
a tank, or the interaction of a single fish with its own reflection in the mirror exposure test 
(mirror-induced aggression, MIA; Fig. 2B)133, 134.
Mounting evidence shows that zebrafish aggression has genetic a basis, and its moderate 
heritability suggests that environmental influences (e.g., maternal care, rearing conditions 
and environmental complexity) also contribute to this behavior. For example, aggression/
boldness profiles in several wild-type zebrafish strains (TM1, SH and Nadia) show strain 
differences in MIA, supporting the genetic basis of aggression in zebrafish136. A group of 40 
genes linked to aggression have been identified in fish, with differences in expression level 
depending on both the area of the brain analyzed and the sex137. HPLC analyses of adult 
zebrafish brains following an aggressive interaction reveal altered DA, 5-HT and their 
metabolites in the telencephalon, diencephalon and optic tectum. Other important brain areas 
include the preoptic area of the anterior hypothalamus138 and the periventricular nucleus of 
the inferior hypothalamus139. Notably, similar brain areas have been linked to agonistic 
behavior in other vertebrates, highlighting the translatability of zebrafish research in this 
field. Like in other vertebrates, fish aggression is controlled by similar neurotransmitters, 
peptides and hormones, including DA, 5-HT, HA, 17α-ethinylestradiol and arginine 
vasopressin/vasotocin (AVP/AVT). For example, addition of estrogen to tank water alters 
zebrafish aggression, implicating certain pathways and circuits133, 140, as reduced 
aggression in dominant male zebrafish correlates with altered 5-HT, DA, AVP levels and the 
expression of the somatostatin pathway genes141.
A recently characterized novel aggressive spiegeldanio mutant zebrafish (spd, Fig. 1A)142 
harbors a mutation in the fgf receptor 1a gene, which disrupts the fibroblast growth factor 
(FGF) signaling in the brain. FGFs are a large family of secreted signaling molecules with 
important roles during development143. Homozygous spd mutants show unaltered 
locomotion but increased aggression, boldness and exploration (Fig. 2B), correlated with 
elevated breakdown of HA in the brain, and reduced neurotransmitter signaling in the 
hypothalamic periventricular nucleus. Importantly, pharmacological increase of HA rescues 
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all three behavioral alterations in spd mutants139. Although spd zebrafish are always more 
aggressive than wild-type siblings, their behavior differs between the laboratories (e.g., 
similar boldness but higher aggression in mutants raised in Germany vs. France)139. Taken 
together, these results demonstrate the importance of environmental influences on 
aggression, and that experimental modulation of selected target genes can strongly affect 
zebrafish aggressive phenotypes.
3.4. PTSD
Severe stress is the main cause of PTSD and other trauma/stress-related disorders (TSRDs). 
Zebrafish have recently been proposed as potential models of PTSD and TSRDs144, 145. The 
extensive, complex repertoire of behavioral responses of zebrafish to a wide variety of 
stress-evoking stimuli closely parallels that observed in mammalian models of PTSD (Fig. 
2C, Table 1)145. For example, various PTSD-relevant phenotypes identified in zebrafish 
include robust anti-predatory responses146, 147 and inhibitory or active avoidance 
conditioning148. Paralleling mammalian tests, an increasing number of zebrafish paradigms 
relevant to PTSD continue to be developed, based on fear conditioning148–152 and exposure 
to aggressive conspecifics134, 138, predators or other acute stressors153–155 (Fig. 2). 
Moreover, the highly social nature of zebrafish156–158 offers further potential to examine 
pathological social phenotypes, representing the serious adverse clinical effects of PTSD/
TSRD. For instance, experimentally evoked disorganization in the social structure of 
zebrafish groups (shoals)158–161 may represent an interesting PTSD-related ‘social 
withdrawal’ phenotype145.
The physiology of zebrafish also supports their suitability for modeling PTSD and other 
stress-related CNS disorders120, 121. Zebrafish rapid development enables time- and cost-
efficient modeling of the developmental and ‘temporal’ pathogenetic aspects of PTSD. 
Moreover, given the strong involvement of the neuroendocrine stress axis in PTSD162, the 
cortisol-driven neuroendocrine axis of zebrafish makes them well-suited for studying 
glucocorticoid regulation in stress and PTSD163, 164. For example, zebrafish grs357 mutants, 
possessing non-functional glucocorticoid receptors, have recently offered a model of 
glucocorticoid resistance to study the developmental effects of glucocorticoid signaling 
deficits on stress physiology and related behaviors165, 166. Furthermore, an extensive array 
of homologues of clinical biomarkers of PTSD has also been identified in zebrafish, 
including corticotropin releasing factor167, 168, glucocorticoid receptor169, 170, 
adrenocorticotropic hormone171, 172, neuropeptide Y173, 174, catechol O-
methyltransferase5, 175, 176 and monoamine oxidase A/B171, 177. Finally, the sensitivity of 
zebrafish sympathetic and parasympathetic responses (e.g., altered heart rate) to 
pharmacological manipulation has recently been established178, offering the potential to 
study autonomic biomarkers of PTSD-relevant drug treatments. Overall, zebrafish emerge as 
a promising new model to complement traditional rodent models of PTSD10, 144, 145.
3.5. Addiction, substance abuse
Zebrafish are increasingly utilized as a preclinical model to investigate molecular 
mechanisms of substance abuse. Drugs of abuse typically exert their effects by modulating 
DA pathways in the midbrain179, and the ascending DA systems (VTA-NAc reward 
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pathway) in zebrafish share functional homology with those of mammals180, 181. Zebrafish 
express orthologs for many addiction-related human genes182, including the majority of the 
DA-, 5-HT- and cholinergic receptor gene families. Zebrafish also display robust reward 
responses to translationally relevant doses of common drugs of abuse, including stimulants 
(cocaine183, amphetamine184, nicotine185 and caffeine; Brock and Brennan, unpublished 
data), ethanol185, opiates (morphine186, fentanyl) and general anaesthetics (tetracaine and 
ketamine; Brock and Brennan, unpublished data). As drug-seeking behavior is 
evolutionarily conserved, zebrafish represent a powerful in-vivo model to assess the 
contribution of genetic factors across specific endophenotypes or drugs of abuse.
The first systematic screens relevant to addiction, examining mutant alleles affecting 
catecholaminergic neurons187, showed that DA/hypothalamic neuronal development is 
regulated by forebrain embryonic zinc finger-like protein (fezl)188, the mutation of which in 
zebrafish reduces opiate (but not food) reward189. Subsequent studies performed 
conditioned place preference (CPP, Fig. 2D) screens of ENU-mutagenized F2 adult fish for 
cocaine and amphetamine reward183, and found a number of families showing heritable 
reduced reward sensitivity184. For instance, the nad+/− mutant zebrafish show insensitivity 
to the rewarding effects of amphetamine190. Microarray analysis, followed by qPCR 
confirmation, identified multiple genes that were up/down-regulated in the nad mutant, 
particularly relating to neurogenesis and brain development. Similar approaches have been 
applied to assess drug-induced reward and to identify novel genes and molecular pathways 
involved in zebrafish reward184, 189, 191–194. For example, mutants heterozygous for a 
nonsense mutation in the AChE (ache+/−) gene184 display reduced amphetamine-induced 
reward in a modified CPP paradigm, demonstrating the conservation of cholinergic 
regulation of reward pathways.
Although sensitivity to the rewarding effects of drugs is a fundamental aspect of 
vulnerability to addiction, addiction itself is characterized by the progression from 
occasional or transient to habitual drug taking, compulsive drug seeking and a tendency to 
relapse even after prolonged abstinence195. Drug-seeking despite adverse consequences, and 
reinstatement of drug seeking following extinction, are both commonly used to model these 
behaviors in laboratory species196. Recent studies demonstrate persistent drug-seeking 
despite punishment197 and relapse198 in zebrafish chronically exposed to either nicotine or 
ethanol. Microarray analysis in this model reveals shared changes in gene expression, 
consistent with conservation of neuroadaptations and the establishment of dependence in 
zebrafish197. Collectively, these findings show that genetic and neural pathways are well 
conserved between mammals and fish, and that fish employ similar molecular adaptations 
following chronic drug exposure199.
In addition to classical screening techniques in adult fish to identify strains with aberrant 
drug responsivity, more targeted approaches help identify specific genes involved in drug 
sensitivity. Fluorescently tagged GBT mutagenesis has been used to examine molecular 
influences on a measure of nicotine addiction, behavioral sensitization116. This insertional 
method represents a leap forward from classic mutagenesis, enabling both visual 
identification of carriers and rapid identification of the disrupted gene. In a screen of GBT 
mutant strains for nicotine behavioral sensitization, 5-dpf larvae were exposed to nicotine 
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acutely or 8 h following previous administration of this drug. Acute exposure caused an 
overt locomotor response, significantly accentuated in the larvae pre-treated with nicotine. 
GBT-mutagenized families with diminished acute and sensitized responses to nicotine, 
identified in this screen, included the bdav mutants with a truncation in chaperonin-
containing protein 8 (ccb8, linked to nicotinic acetylcholine receptor nAChR), and the hbog 
zebrafish with a mutant ortholog of the GABA-B receptor (gabbr1.2)59, 116. Furthermore, 
the behavioral phenotypes in these strains were reverted by cre-mediated recombination, 
revealing specific loci in zebrafish that may lead to translational targets for the treatment of 
tobacco addiction116.
3.6. Alcohol
Alcohol is the drug with the longest history of use and abuse in human society. Although 
legally accepted and culturally tolerated, it is a dangerous drug, and alcohol-related 
disorders present an enormous burden for the patient and society200. Alcohol is a complex 
drug, affecting multiple mechanisms and behaviors in a dose- and use-dependent manner. 
This complexity is one of the reasons why effective therapies are still lacking, and alcohol-
related disorders remain a serious medical concern. In general, findings from zebrafish 
alcohol research can by evaluated by three main criteria of a translationally acceptable 
model – face, construct and predictive validity. Addressing face validity, recent studies 
suggest that zebrafish respond to alcohol in a manner highly homologous to that of 
humans133 (Fig. 2E). For example, acute administration of alcohol makes fish agitated at 
intermediate doses, but lethargic at higher doses201. Zebrafish exhibit motor impairment in 
response to high doses of acute alcohol (e.g., 1%), but show elevated aggression in response 
to intermediate (e.g., 0.25–0.50%) doses133. Acute alcohol also impairs zebrafish response 
to social stimuli in a linear dose-dependent manner (Fig. 2E), a reaction that is strikingly 
similar to that in humans133, 202. Chronic exposure to alcohol evokes tolerance in zebrafish, 
paralleling clinical findings203. Withdrawal from alcohol also leads to responses (e.g., 
elevated motor activity, anxiety, incoordination and reduced shoaling), phenotypically 
similar in zebrafish and humans203, 204 (Fig. 2E). Likewise, embryonic alcohol exposure in 
zebrafish further parallels the clinical effects of embryonic alcohol exposure, including the 
social and learning impairment observed in fetal alcohol spectrum disorders (FASD)10, 205.
Mounting evidence also suggests significant construct validity of zebrafish alcohol models. 
For example, following acute or chronic alcohol treatment, zebrafish show similar 
neurochemical alterations in the brain, compared to humans. Acute alcohol induces a rapid 
increase in brain DA, which is blunted after chronic alcohol exposure203. Likewise, 
withdrawal from alcohol increases brain DA levels203, whereas chronic alcohol exposure 
alters the expression of nearly 2000 genes in zebrafish, many of which have been implicated 
in human alcoholism206.
One of the greatest challenges for modeling the effects of alcohol in zebrafish is establishing 
predictive validity – the extent to which drugs (with particular known effects on human 
CNS) act in the same way in the zebrafish system. While the model system is expected to 
show efficacy of human drugs in the predicted manner, only a limited number of compounds 
expected to mediate the effects of alcohol has been assessed in zebrafish. However, 
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zebrafish have largely been shown to respond in a predictable manner to such compounds, 
paralleling clinical effects and suggesting a conservation of the main neurotransmitter 
signaling pathways between zebrafish and humans. Overall, while future studies are needed 
to further assess their face, construct and predictive validity as models of alcohol-related 
disorders, zebrafish already shows a significant potential in this field.
4. Current challenges
The advantages and limitations of zebrafish in biopsychiatry research have recently been 
discussed in the literature9–11, 174. However, despite recent progress in zebrafish 
neurobiology, many important questions remain to be addressed. For example, the logical 
step in the development of zebrafish models with translational relevance to human addiction 
is to apply systematic screening of mutagenized families, to characterize genetic risk factors 
associated with drug abuse. Humans with addiction and other linked psychiatric disorders 
(e.g., compulsive gambling, obsessive compulsive disorder, Tourette’s syndrome or ADHD) 
often display deficits in general cognitive or executive function207–210 (which becomes 
relevant to studying the molecular basis of cognitive dysfunction linked to addiction). 
Emerging as a key endophenotype for cocaine addiction211, 212, trait impulsivity represents 
several behavioral constructs, including inability/unwillingness to wait, choice of smaller 
but more immediate (over larger, delayed) rewards, and motor impulsivity (failure to inhibit 
a pre-potent response)213. In compulsive drug use in rodents, animals with high levels of 
motor impulsivity (assessed by premature responses on a test of sustained attention, the five-
choice serial reaction time task; 5-CSRTT214) also show compulsive cocaine seeking211 and 
increased relapse after extinction training215. This task has recently been adapted for 
zebrafish216, resulting in a fully automated model217, validated pharmacologically by 
showing dose-dependent reductions in fish impulsivity following atomoxetine218, similar to 
rodents219. Collectively, this provides the exciting prospect of using three-generation 
screens (discussed above) or insertional transposon technologies to study impulsivity, thus 
fostering the search for the molecular basis of psychiatric disorders linked to impulsivity and 
other reward-related traits.
Likewise, the ability to develop novel zebrafish models of ADHD is also interesting and 
translationally relevant. However, the suitability of zebrafish models (e.g., mutants lacking 
lphn3.1 function) as an ADHD-like model must be further established by testing other 
behaviors, such as performance in the 5-CSRTT217. Although such a complex task will 
require a stable lphn3.1 line to be established, this approach would be ideal to reinforce the 
utility of lphn3.1 and other mutant fish as a tool to study the neurobiology of ADHD.
Because the formation, position and function of neurotransmitter signaling pathways 
sometimes differ between zebrafish and other vertebrates, comparative studies become 
important. For example, as already mentioned, similar to other teleosts, zebrafish have 
undergone a partial genome duplication, and some genes found in a single copy on the 
mammalian chromosome have two copies in the zebrafish chromosome220. Such genetic 
redundancy can make it more difficult to analyze a disease gene’s function (e.g., if the effect 
of a mutated gene is masked by the unaltered ‘sister’ gene). While the function of some 
receptors and transporters is conserved across species17, 65, the increased spectrum of 
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neurotransmitter signaling-related molecules in zebrafish (vs. mammals) suggests that their 
functional properties merit further scrutiny in genetic and pharmacological studies. 
However, this redundancy can also present an opportunity (e.g., permitting the analysis of 
the effects of genes whose null mutations lead to developmental lethality if in a single copy, 
a common problem in mouse knockout studies).
From an evolutionary perspective, there are also important physiological differences 
between mammals and zebrafish. For example, fish are poikiloterms and mammals are 
homeothermic animals, and substantial differences exist in metabolism and organ systems 
between species221. Likewise, there are also well-known differences in brain development 
between fish and mammals, which will be only briefly mentioned here. For instance, instead 
of the laminar cortex, telencephalic nuclei in teleost fishes have evolved as the pallium, 
containing similar but simpler neural circuits, compared with the mammalian cortex, which 
also has some additional circuits222 (note, however, recent data showing that emotions and 
motivated behavior in zebrafish converge on an amygdala-like structure, similar to their 
mammalian counterparts111). Another interesting example is the habenula - a key relay 
nucleus connecting the forebrain with the brainstem and modulating monoaminergic 
mechanisms of behavior and cognition223. Although the development of its circuits appears 
to be conserved phylogenetically, some species differences in habenular asymmetry exist 
between fish and mammals223 (note, however, mounting evidence showing that the 
zebrafish habenula, like in humans224, plays an important role in the regulation of affective 
behavior and aversive memories152, 225–227). While not within the scope of this review, such 
physiological and neurobiological differences between species must be considered critically 
when translating zebrafish responses into human disorders221. Together with some genetic 
differences between species12 and poorly characterized protein function differences 
(stemming from divergent evolution), this represents a serious current challenge for 
zebrafish molecular psychiatry.
Finally, perhaps the biggest challenge in multidisciplinary zebrafish studies is the behavioral 
models and tools9, 10. Despite a rapidly growing research in this field, the zebrafish is still a 
new model in behavioral neuroscience11. Will zebrafish analyses keep pace with the rapid 
advancement of molecular and neurobiological tools developed for this species? While the 
answer to this question is unclear, recent evidence offers grounds for optimism. For 
example, the rapidly increasing computer processing power, coupled with constantly 
improving 2D and 3D video-recording and imaging tools, generates behavioral data with 
ever increasing quality, precision and spatiotemporal resolution. Simultaneous video-
tracking of a large number of fish (either swimming in separate compartments; Fig. 2B or 
moving together in a group/shoal)10, 160 now became a reality. As behavioral quantification 
becomes more precise, so does the delivery of stimuli that induce the behavioral responses. 
Because both stimulus delivery and behavioral response quantification are now increasingly 
computerized and standardized, the behavioral paradigms in zebrafish become more 
automated and scalable. Thus, running such multiple tasks in parallel makes even slow 
learning protocols high-throughput and efficient. Enhancing high-throughput screening of 
mutants and drugs that affect complex behavioral responses, such phenomics-based 
approaches in zebrafish foster further experimental modeling of human brain disorders.
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5. Conclusion
Uncovering the molecular processes that underlie the formation of neural circuits and their 
activity to control the behavior, is key to the understanding and treatment of psychiatric 
diseases6, 7. Recognizing the importance of zebrafish to molecular psychiatry is the critical 
step in our continued use of this model organism to study neurobiological mechanisms of 
human brain disorders. In addition to the growing availability of genetic and 
pharmacological assays and probes in zebrafish, there is also an urgent need for new 
behavioral assays and imaging neural pathways and circuits implicated in various 
pathological states in this species228, 229.
The availability of genetic, electrophysiological and optogenetic tools, as well as multiple 
mutant and transgenic strains, physiological biomarkers and robust protocols to measure 
behavior, collectively supports zebrafish potential for modeling psychiatric disorders. As 
both larval and adult zebrafish are now rapidly becoming key model organisms in 
neuroscience research, they represent a useful novel species for translational molecular 
psychiatry and CNS drug discovery.
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Abbreviations
5-CSRTT 5 choice serial reaction time task
5-HT 5-hydroxytryptamine (serotonin)
AChE Acetylcholinesterase
ADD/ADHD Attention deficit disorder and attention deficit hyperactivity disorder
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
AP Area postrema
CNiFERs Cell-based sensors of neurotransmitters
ChAT Choline acetyltransferase
dpf Days post fertilization
EAATs High-affinity excitatory amino acid transporters
EOS Glutamate optical sensor
FFN Fluorescent false neurotransmitters
GABA γ:-Aminobutyric acid
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GAD Glutamic acid decarboxylase
GECIs Genetically encoded calcium indicators
GFP Green fluorescent protein
hpf Hours post fertilization
iGluR glutamate ionotropic receptor
iGluSnFR Intensity-based glutamate-sensing fluorescent reports
ir Immunoreactive
LO Locus coeruleus
mGluR Glutamate metabotropic receptor
MO Medulla oblongata
NMDA N-methyl-D-aspartate
Pax3 ‘Paired box’, 3 (gene)
TILLING Targeting induced local lesions in genomes
TALEN Transcription activator-like effector nuclease
VGLUT Vesicular glutamate transporter
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Figure 1. A brief summary of zebrafish experimental models in neuroscience research
Panel A shows the evolving nature of zebrafish models in the last 50 years, initially used 
mainly for basic genetic and neurodevelopmental studies, but more recently applied to 
developing in-vivo models for complex brain disorders, such as autism, depression and 
psychoses. Inset: selected zebrafish strains useful in biological psychiatry research (top to 
bottom: adult wild type zebrafish, casper, spiegeldanio and nacre mutants); photos courtesy 
of the Kalueff (ZENEREI Institute, USA), the Norton (University of Leicester, UK), the 
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Parichy (University of Washington, USA) laboratories and Carolina Biological Supply 
Company (Burlington, USA).
Panel B illustrates two research strategies which can both be applied to zebrafish models. 
As a vertebrate species amenable to in-vivo analyses and with high genetic/physiological 
homology to humans, zebrafish are ideal for ‘intensive’, mechanistically driven 
neuroscience research into conserved, core molecular pathways or neural circuits (photo). 
Due to their small size, ease of maintenance and short generation time, zebrafish also 
represent an excellent model for ‘extensive’ biomedical research, including low-cost high-
throughput screening for small molecules or genetic mutations. Both strategies can lead to 
the development of novel therapies for major psychiatric disorders. Photo: visualizing 
zebrafish signaling as an example of intensive, pathway-oriented mechanistic research (the 
left image shows expression patterns of genetically encoded calcium indicator; zebrafish at 5 
dpf show pan-neuronal expression of HuC:Gal4; UAS:GCaMP5, a zoomed-in image on the 
right shows a single cell resolution: note that some cells are activated, as indicated by the 
increased fluorescence; scale bar 100 µm).
Panel C illustrates the benefits of including inexpensive zebrafish models into preclinical 
screening batteries. A substantial fiscal saving (shown as $) can be achieved by narrowing 
screening to potentially active compounds using fish (rather than mice) as the first vertebrate 
model organism in the screening pipeline. In addition, the risks of missing promising ‘hits’ 
are lower because the subsequent screening in mammals will be ‘confirmatory’, and based 
on more valid data generated from zebrafish (rather than invertebrate or in-vitro) tests.
Panel D summarizes major neurotransmitter systems in the adult zebrafish brain: ACh - 
acetylcholine (dark blue), NA - noradrenergic (purple), DA - dopamine (green), HA - 
histamine (orange), 5-HT - serotonin (red); GABA - γ-aminobutyric acid (pink), Glu - 
glutamate (light blue). The highlighted brain regions include olfactory bulb (OB), dorsal 
pallium (Dp), ventral pallium (Vp), habenula (Ha), optic nerve (ON), facial lobe (LVII) and 
vagal lobe (LX). Highlighted areas have been overlaid over a minimum deformation model 
of the adult zebrafish brain.
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Figure 2. Neurobehavioral phenotypes in zebrafish relevant to modeling a diverse group of 
psychiatric disorders (also see Table 1)
Axis represent five major phenotypic domains of brain disorders, and include motor activity, 
cognition, affect/emotionality, reward and aggression. A dashed- line pentagon represents 
‘normal’ healthy phenotype for each respective axis/domains.
Panel A shows typical zebrafish responses relevant to ADHD (modified from 125, 126). The 
bar diagram shows total distance swum in 5 min for control larvae and lphn3.1 morphants 
with and without methylphenidate (MPH) treatment. The right panel shows representative 
locomotion traces (recorded from the top view camera) in 6-dpf control and lphn3.1 
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morphant zebrafish (green color indicates swimming with normal speed, red color indicates 
bursts of ‘impulsive’ swimming with high-acceleration).
Panel B illustrates zebrafish mirror-induced aggression (MIA) responses in the mirror 
exposure test, and typical patterns of zebrafish aggressive confrontations (modified 
from 139). Note that MIA is particularly simple to record and quantify161, making it also 
suitable for high-throughput screening (MIA images in the middle: courtesy of the Robison 
laboratory161, University of Idaho, USA).
Panel C illustrates zebrafish stress- and PTSD-related aversive behaviors, including 
neophobia (e.g., acute 5-min exposure to the unfamiliar blue marble in the novel object test) 
and predator avoidance (acute 5-min exposure to a predator fish). Note that zebrafish avoid a 
blue marble at the bottom of the tank (swim traces in the open field test recorded by Noldus 
Ethovision XT8 from the top view), as well as display robust aversion of a live predator 
(e.g., Leaf fish), clearly spending more time in the opposite side of the tank.
Panel D demonstrates zebrafish reward-related addiction behaviors (in the conditioned place 
preference model, CPP) and molecular alterations in zebrafish brain following exposure to a 
substance of abuse. In the CPP, fish are initially tested for their preference for both sides of 
the apparatus, each of which contains a discriminative stimulus (i.e., spots vs. no spots). 
They are then conditioned with drug to the least-preferred side over a number of sessions. 
Finally, their preference is assessed again in a probe trial, where the rewarding value of the 
drug can be ascertained by calculating the change in preference for the least-preferred side 
following conditioning (in addition to water immersion, also note the use of i.p. drug 
injections in some zebrafish CPP studies184, 190). The bottom right bar diagram also shows a 
classic dose-response curve for nicotine in adult fish (also note that mutant heterozygous for 
a nonsense mutation for the acetlycholinesterase gene (achesb55/+) do not show place 
preference for 6 µM nicotine; Brock et al., unpublished observations). Top right bar diagram 
shows fish that display persistent compulsive drug seeking (i.e., drug seeking despite 
adverse consequences/punishment) following chronic exposure to ethanol or nicotine, also 
demonstrating long-lasting drug-specific and conserved changes in gene expression197 
(brain genes’ microarray, inset).
Panel E shows the reduction in zebrafish social behavior (e.g., shorter distance between a 
test fish and moving shoaling images delivered on a computer screen; inset). This reduction 
in hoaling response is abolished by acute administration of a high concentration of alcohol, 
which was inactive in fish chronically pre-treated with alcohol. Withdrawal from alcohol 
chronic exposure also abolishes the shoaling response. Note that alcohol-induced behavioral 
changes in zebrafish are closely paralleled by alterations in DA levels quantified from whole 
brain samples using HPLC (modified from 203, 230).
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Table 1
Examples of a diverse group of psychiatric disorders (Fig. 2) which can be modeled in zebrafish (see 135 for a 
comprehensive catalog of zebrafish normal and pathological behaviors).
Selected disorders Zebrafish phenotypes References
Attention deficit 
hyperactivity disorder 
(ADHD)
Impulsive swimming with hyperactive locomotion and impulsivity-like bursts of 
accelerated swimming, which can be reduced by anti-ADHD drugs (Fig. 2A)
125, 126, 217, 218, 231
Aggression Social deficits (disrupted shoaling behavior), increased aggressive behaviors 
(follows, chases and biting), mirror-induced aggression, MIA (Fig. 2B)
135, 139, 161
Post-traumatic stress 
disorder (PTSD)
Reduced exploration following stress, increased avoidance (e.g., neophobia; Fig. 
2C), erratic behavior and freezing, elevated cortisol and brain c-fos (all highly 
sensitive to a wide range of anxiolytic and anxiogenic agents), social deficits (e.g., 
disrupted shoaling behavior)
144, 146, 147, 232
Substance abuse, addiction 
(reward-related behavior)
Robust conditioned preference for commonly abused substances, compulsive drug 
seeking (i.e., despite adverse consequences; Fig 2D), withdrawal syndrome, 
stimulus-induced relapse following extinction, altered social behavior (Fig. 2E)
197, 198, 201, 202, 205, 233–235
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